Rachel A Burge
5PUBLICATIONS
61CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 20, 2026
KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment.Rachel A Burge, Ozgun Le Roux, Olesja Popow
|Oct 24, 2025
PTEN Oxidation Promotes Constitutive PI3K Signaling and Inducible Macropinocytosis in Pancreatic Cancer.Rachel A Burge, Lucas Bialousow, Amanda J Linke
|Oct 24, 2025
Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.Mandana Kamgar, G Aaron Hobbes, Raven Davidson
|Sep 15, 2025
Pancreatic Cells Are Resistant to KRASQ61L Expression due to Hyperactive ERK/MAPK Signaling and Apoptosis Induction.Rachel A Burge, Lucas Bialousow, Thomas McFall
|Dec 27, 2024
A High-Affinity Monoclonal Antibody Against the Pancreatic Ductal Adenocarcinoma Target, Anterior Gradient-2 (AGR2/PDIA17).Reeder M Robinson, Leticia Reyes, Benjamin N Christopher
Pageof 1
Frequent Collaborators
5 joint publications
G Aaron Hobbs
3 joint publications
Lucas Bialousow
3 joint publications
Thomas McFall
2 joint publications
David F Kashatus
2 joint publications
Todd W Bauer
2 joint publications
Merissa Smith
2 joint publications
Silvia G Vaena
2 joint publications
Sara J Adair
2 joint publications
Channing J Der
1 joint publications
Christopher M Counter
